drugset / Trial / NCT00744549
Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance
Phase 2
Completed
16 enrolled
University Health Network, Toronto
The Prostate Cancer Research Foundation of Canada · collab
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to determine whether antioxidants (vitamin E, selenium and lycopene)can change(reduce)prostate tumor size or blood flow to the prostate as determined by MRI imaging among men on Active Surveillance.
Timeline
- Start
- 2008-05
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cholecalciferol | Other / unclassified | 200 iu | — |
| Subject | Lycopene | Other / unclassified | 20 mg | — |
| Subject | Selenium | Other / unclassified | 100 ug | — |
| Subject | Vitamin E | Other / unclassified | 50 iu | — |
| Subject | green tea extract | Unknown | 75 mg | — |